Article Versions Notes

Vidali S, Irmici G, Depretto C, Bellini C, Pugliese F, Incardona LA, Di Naro F, De Benedetto D, Di Filippo G, Ferraro F, et al. Performance of Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response among Different Breast Cancer Subtypes. Cancers. 2024; 16(15):2694. https://doi.org/10.3390/cancers16152694

Vidali, Sofia, Giovanni Irmici, Catherine Depretto, Chiara Bellini, Francesca Pugliese, Ludovica Anna Incardona, Federica Di Naro, Diego De Benedetto, Giacomo Di Filippo, Fabiola Ferraro, and et al. 2024. "Performance of Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response among Different Breast Cancer Subtypes" Cancers 16, no. 15: 2694. https://doi.org/10.3390/cancers16152694

Vidali, S., Irmici, G., Depretto, C., Bellini, C., Pugliese, F., Incardona, L. A., Di Naro, F., De Benedetto, D., Di Filippo, G., Ferraro, F., De Berardinis, C., Miele, V., Scaperrotta, G., & Nori Cucchiari, J. (2024). Performance of Contrast-Enhanced Mammography (CEM) for Monitoring Neoadjuvant Chemotherapy Response among Different Breast Cancer Subtypes. Cancers, 16(15), 2694. https://doi.org/10.3390/cancers16152694